Javascript must be enabled to continue!
Study on biological activities of herbs’ decoction combining Scutellaria barbata, Hedyotis diffusa and Ehretia asperula
View through CrossRef
Background: Cancer is a leading cause of death worldwide. Nowadays, cancer is often treated with different methods, such as surgery, radiation therapy, and chemotherapy. However, these methods have lots of side effects for patients, so natural products are often combined with them to diminish those side effects. According to oriental medicine, there are many folk remedies to support cancer treatment. Each different type of cancer has corresponding remedies. In particular, to support the liver cancer treatment, some medicinal herbs were used, such as Scutellaria barbata, Hedyotis diffusa, Ehretia asperula. The aim of the study: Determining the biological activities of herbal decoctions combining Scutellaria barbata, Hedyotis diffusa, and Ehretia asperula, which were tested on two different weight ratio recipes (denoted R1 and R2). Materials and methods: Mixing Scutellaria barbata, Hedyotis diffusa, and Ehretia asperula into dry mixtures and then collecting the decoction. Testing antioxidant activity by the reducing power assay and the DPPH free radical scavenging assay. Evaluating antibacterial activity by the agar well diffusion assay and cytotoxic ability by the sulforhodamine B assay. Results: R1 decoction, which had a higher ratio of E. asperula, showed greater antioxidant, antibacterial, and cytotoxic capacity than R2 decoction. In the reducing power assay, R1 decoction's optical density value was 2.80, while the other was 2.23 at 0.7% concentration. In the DPPH free radical scavenging assay, the EC50 values of R1 and R2 decoctions were 0.022% and 0.035%, respectively. Both R1 and R2 decoctions had antimicrobial activities against Bacillus subtilis at 100% concentration, as shown by the diameters of inhibition growth zones of 11.33 mm and 7.40 mm, respectively. In the Sulforhodamine B assay, R1 decoction's IC50 was 0.47%, and R2 decoction's IC50 was 0.66%. Conclusion: In the same condition, R1 decoction had better tested biological activities than R2 decoction.
Belgorod National Research University
Title: Study on biological activities of herbs’ decoction combining Scutellaria barbata, Hedyotis diffusa and Ehretia asperula
Description:
Background: Cancer is a leading cause of death worldwide.
Nowadays, cancer is often treated with different methods, such as surgery, radiation therapy, and chemotherapy.
However, these methods have lots of side effects for patients, so natural products are often combined with them to diminish those side effects.
According to oriental medicine, there are many folk remedies to support cancer treatment.
Each different type of cancer has corresponding remedies.
In particular, to support the liver cancer treatment, some medicinal herbs were used, such as Scutellaria barbata, Hedyotis diffusa, Ehretia asperula.
The aim of the study: Determining the biological activities of herbal decoctions combining Scutellaria barbata, Hedyotis diffusa, and Ehretia asperula, which were tested on two different weight ratio recipes (denoted R1 and R2).
Materials and methods: Mixing Scutellaria barbata, Hedyotis diffusa, and Ehretia asperula into dry mixtures and then collecting the decoction.
Testing antioxidant activity by the reducing power assay and the DPPH free radical scavenging assay.
Evaluating antibacterial activity by the agar well diffusion assay and cytotoxic ability by the sulforhodamine B assay.
Results: R1 decoction, which had a higher ratio of E.
asperula, showed greater antioxidant, antibacterial, and cytotoxic capacity than R2 decoction.
In the reducing power assay, R1 decoction's optical density value was 2.
80, while the other was 2.
23 at 0.
7% concentration.
In the DPPH free radical scavenging assay, the EC50 values of R1 and R2 decoctions were 0.
022% and 0.
035%, respectively.
Both R1 and R2 decoctions had antimicrobial activities against Bacillus subtilis at 100% concentration, as shown by the diameters of inhibition growth zones of 11.
33 mm and 7.
40 mm, respectively.
In the Sulforhodamine B assay, R1 decoction's IC50 was 0.
47%, and R2 decoction's IC50 was 0.
66%.
Conclusion: In the same condition, R1 decoction had better tested biological activities than R2 decoction.
Related Results
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
GW24-e2123 Effect of Sini Decoction on the expression of Sirt-1 and eNOS system in EAhy926 cells injured by homocysteine
Objectives
To detect the effect of Sini Decoction on the expression of Sirt-1 and eNOS in EAhy926 cell injured by homocysteine.
...
Winyanghuayin Decoction and Xiaoqinglong Decoction Treatment Airway Inflammation of Cold Asthma Through PI3K-mTOR Signal Pathway
Winyanghuayin Decoction and Xiaoqinglong Decoction Treatment Airway Inflammation of Cold Asthma Through PI3K-mTOR Signal Pathway
Abstract
Background: Airway inflammation plays a pivotal role in cold asthma. Winyanghuayin decoction and Xiaoqinglong decoction can significantly improve airway inflammati...
Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment
Observation on the Efficacy of Self-formulated Huatan Chushi Zhuyu Decoction in the Treatment of Adenoid Hypertrophy in Children and Literature Research on Traditional Chinese Medicine Treatment
To observe the clinical efficacy of the self-formulated Huatan Chushi Zhuyu Decoction (HCZ Decoction) combined with basic Western medical treatment in children with moderate to sev...
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
EFFECT OF SINI DECOCTION ON THE EXPRESSION OF CAVEOLIN-1 AND ENOS IN EAHY926 CELL INJURED BY HOMOCYSTEINE
Objectives
To detect the effect of Sini Decoction on the expression of Caveolin-1 and eNOS in EAhy926 cell injured by homocysteine.
...
Abstract 1043: Efficacy and mechanistic insights of Shengyang Qushi Decoction in managing surufatinib-associated diarrhea
Abstract 1043: Efficacy and mechanistic insights of Shengyang Qushi Decoction in managing surufatinib-associated diarrhea
Abstract
Background:
Surufatinib, a novel TKI targeting VEGFRs, FGFR1, and CSF1R, treats advanced neuroendocrine tumors but ofte...
Integrating network pharmacology and in vivo pharmacological investigation for deciphering the mechanism of Simiao Yong’an decoction in alleviating rheumatoid arthritis
Integrating network pharmacology and in vivo pharmacological investigation for deciphering the mechanism of Simiao Yong’an decoction in alleviating rheumatoid arthritis
Objective:
To investigate the mechanism of Simiao Yong’an Decoction in alleviating the damage of rheumatoid arthritis (RA), and accordingly provide pharmacological evid...
The Mechanism Study of Xiao-Xian-Xiong Decoction in the Treatment of Atherosclerosis with Network Pharmacology
The Mechanism Study of Xiao-Xian-Xiong Decoction in the Treatment of Atherosclerosis with Network Pharmacology
Abstract
Background: Xiao-Xian-Xiong decoction is a useful formula in the treatment of atherosclerosis in traditional Chinese medicine. In this study, we aimed to investiga...
Nitric oxide (NO) radical inhibitory of hedyotis philippinensis and its marker compound, asperuloside
Nitric oxide (NO) radical inhibitory of hedyotis philippinensis and its marker compound, asperuloside
Hedyotis spesies have been used in Chinese folk medicine as a treatment for colds, stomatitis and various inflammations. In this study, three methanolic extracts of Hedyotis specie...

